Fenoldopam is an effective intravenous treatment option for managing severe hypertension.
Answers are grounded in this paper and cite their sources.
May support fenoldopam in severe hypertension; leaves open need for randomized trials before practice change.
Fenoldopam is a peripherally acting dopamine-receptor agonist that has vasodilator and diuretic actions. Given intravenously, it is an effective treatment for patients with severe hypertension, including those with hypertensive encephalopathy and perioperative hypertension. This review summarizes the pharmacologic characteristics of fenoldopam and its efficacy as a treatment for patients with severe hypertension.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: